Adjuvant chemotherapy for endometrial cancer

International Journal of Gynecological Cancer

Volumn 21, Issue 5, 2011, Pages 885-895

  Tangjitgamol, Siriwan ^a   See, Hui Ti ^b   Kavanagh, John ^c  

^a NAVAMINDRADHIRAJ UNIVERSITY   (Thailand)

^b GLENEAGLES HOSPITAL   (Singapore)

^c CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Adjuvant chemotherapy; Endometrial cancer; Sequential chemotherapy after radiation

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; PACLITAXEL;

ANEMIA; BLOOD TOXICITY; BONE NECROSIS; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CARDIOTOXICITY; COMPARATIVE STUDY; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG FATALITY; DRUG WITHDRAWAL; ENDOMETRIUM CANCER; FEBRILE NEUTROPENIA; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL TOXICITY; HISTOLOGY; HUMAN; LEUKEMIA; LEUKOPENIA; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MINIMAL RESIDUAL DISEASE; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; MYALGIA; MYOFIBROSIS; MYOMETRIUM; NEUROTOXICITY; NEUTROPENIA; PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SENSORY NEUROPATHY; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VAGINA DISEASE;

EID: 82955186386     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e3182169239     Document Type: Review

References (23)

1. Keys HM, Roberts JA, Brunetto VL, et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: A Gynecologic Oncology Group study. Gynecol Oncol. 2004;92:744-751. (Pubitemid 38251372)
2. Creutzberg CL, van Putten WL, Koper PC, et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: Multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet. 2000;355:1404-1411. (Pubitemid 30215963)
3. ASTEC/EN.5 Study Group, Blake P, Swart AM, Orton J, et al. Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): Pooled trial results, systematic review, and meta-analysis. Lancet. 2009;373:137-146.
4. Johnson N, Bryant A, Miles Tet al, Cochrane Gynaecological Cancer Review Group. Systemic Cochrane review examining the role of adjuvant chemotherapy for endometrial cancer. Proceedings of the 13th International Gynecologic Cancer Society; October 23-26, 2010; Prague, Czech Republic. Abstract 11.
5. Morrow CP, Bundy BN, Homesley HD, et al. Doxorubicin as an adjuvant following surgery and radiation therapy in patients with high-risk endometrial carcinoma, stage I and occult stage II: A Gynecologic Oncology Group Study. Gynecol Oncol. 1990;36:166-171. (Pubitemid 20061279)
6. Randall ME, Filiaci VL, Muss H, et al. Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: A Gynecologic Oncology Group Study. J Clin Oncol. 2006;24:36-44. (Pubitemid 46630491)
7. Homesley HD, Filiaci V, Gibbons SK, et al. Randomized phase III trial in advanced endometrial carcinoma of surgery and volume-directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: A Gynecologic Oncology Group study. Gynecol Oncol. 2009;112:543-552.
8. Kuoppala T, Mäenpää J, Tomas E, et al. Surgically staged high-risk endometrial cancer: Randomized study of adjuvant radiotherapy alone vs. sequential chemo-radiotherapy. Gynecol Oncol. 2008;110:190-195.
9. Maggi R, Lissoni A, Spina F, et al. Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: Results of a randomised trial. Br J Cancer. 2006;95:266-271. (Pubitemid 44187586)
10. Susumu N, Sagae S, Udagawa Y, et al. Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: A Japanese Gynecologic Oncology Group study. Gynecol Oncol. 2008;108:226-233. (Pubitemid 350299451)
11. Hogberg T, Signorelli M, de Oliveira CF, et al. Sequential adjuvant chemotherapy and radiotherapy in endometrial cancerVresults from two randomised studies. Eur J Cancer. 2010;46:2422-2431.
12. Hogberg T, Rosenberg P, Kristensen G, et al. A randomized phase-III study on adjuvant treatment with radiation (RT) T chemotherapy (CT) in early stage high-risk endometrial cancer (NSGO-EC-9501/EORTC 55991). J Clin Oncol. 2007;25: Abstract 5503.
13. ASTEC study group, Kitchener H, Swart AM, Qian Q, et al. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): A randomised study. Lancet. 2009;373:125-136.
14. Benedetti Panici P, Basile S, Maneschi F, et al. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: Randomized clinical trial. J Natl Cancer Inst. 2008;100:1707-1716.
15. Hakmi A. Lymphadenectomy in endometrial cancer. Lancet. 2009;373:1169.
16. Amant F, Neven P, Vergote I. Lymphadenectomy in endometrial cancer. Lancet. 2009;373:1169-1170.
17. Uccella S, Podratz KC, Aletti GD, et al. Lymphadenectomy in endometrial cancer. Lancet. 2009;373:1170.
18. NCT00006027 study synopsis. A phase III study of adjuvant postoperative irradiation with or without cisplatin/taxol chemotherapy following TAH/BSO for patients with endometrial cancer. Updated February 6, 2009. Available at: Http://www.cancer.gov/clinicaltrials/RTOG-9905. Accessed August 5, 2010.
19. NCT00411138 study synopsis. Randomized phase III trial comparing concurrent chemoradiation and adjuvant chemotherapy with pelvic radiation alone in high risk and advanced stage endometrial carcinoma: PORTEC-3. Updated February 6, 2009. Available at: Http://www.clinicalresearch.nl/portec3/. Accessed August 5, 2010.
20. NCT00807768 study synopsis. Pelvic radiation therapy or vaginal implant radiation therapy, paclitaxel, and carboplatin in treating patients with high-risk stage I or stage II endometrial cancer. Updated March 31, 2010. Available at: Http://clinicaltrials.gov/ct2/show/NCT00807768. Accessed August 5, 2010.
21. Greven K, Winter K, Underhill K, et al. Final analysis of RTOG 9708: Adjuvant postoperative irradiation combined with cisplatin/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer. Gynecol Oncol. 2006;103:155-159. (Pubitemid 44374683)
22. Nout RA, Smit VTHBM, Putter H, et al. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): An open-label, non-inferiority, randomised trial. Lancet. 2010;375:816-823.
23. Nout RA, Putter H, Jurgenliemk-Schulz IM, et al. Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: First results of the randomized PORTEC-2 trial. J Clin Oncol. 2009;27:3547-3556.